Obesity disrupts bone metabolism and leads to increased bone resorption, but GLP-1RAs can inhibit this damage and improve bone health by increasing the OPG/RANKL ratio, reducing osteoclast activity, and promoting bone formation
The patient's past medical history included hypertension, treated with bisoprolol for 10 years, and chronic glaucoma, for which she had started topical dorzolamide 2 weeks prior to symptom onset
BioLongevity Labs operates from Akron, Ohio under F2 Nutrition LLC and maintains a public per-batch certificate library that requires no login, which places it in the smaller group of suppliers whose documentation can be evaluated by a first-time visitor
00:06:42 Vickie Danaher So generally speaking, efficacy seems pretty similar if we think about 9% more weight loss than placebo versus 11% more weight loss than with placebo, with oral semaglutide potentially having a very slight edge
They are considered the prototype of the second generation